Thousands of NHS patients in England with multiple sclerosis (MS) are set to benefit from a life-changing ‘take at home’ tablet, as the NHS becomes the first healthcare system in Europe to roll it out ...
Called Phesgo, the new product contains the active substances in Herceptin (trastuzumab) – already facing lower-cost competition in the US and Europe – and Perjeta (pertuzumab), which are both ...
helped by lower costs and growth from drugs such as eye treatment Vabysmo and cancer drug Phesgo. German government, opposition clash over rival border policies Germany's government and opposition ...
Daiichi Sankyo has signed a deal worth up to $300 million with South Korean biotech Alteogen to develop a subcutaneous version of its AstraZeneca-partnered cancer drug Enhertu. Alteogen will ...
“Broadening access to cladribine means thousands more patients will benefit from managing their treatment at home rather than regularly attending hospital appointments – as well giving women with MS ...
After hours: March 10 at 7:29:09 PM EDT Loading Chart for HALO ...
6367.T Daikin Industries,Ltd.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback